BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Go back to BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program| (AMEX: BMKDF) | Delayed: 0.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $0.14 | |||
| Open | $0.40 | 52 Week Low | $0.04 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $0.00 | |||
| Volume | 271,388 | |||||

